77 related articles for article (PubMed ID: 1281185)
1. Evidence for voltage modulation of IL-2 production in mitogen-stimulated human peripheral blood lymphocytes.
Freedman BD; Price MA; Deutsch CJ
J Immunol; 1992 Dec; 149(12):3784-94. PubMed ID: 1281185
[TBL] [Abstract][Full Text] [Related]
2. Charybdotoxin-sensitive, Ca(2+)-dependent membrane potential changes are not involved in human T or B cell activation and proliferation.
Gelfand EW; Or R
J Immunol; 1991 Nov; 147(10):3452-8. PubMed ID: 1719077
[TBL] [Abstract][Full Text] [Related]
3. Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin.
Leonard RJ; Garcia ML; Slaughter RS; Reuben JP
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10094-8. PubMed ID: 1279670
[TBL] [Abstract][Full Text] [Related]
4. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation.
Lin CS; Boltz RC; Blake JT; Nguyen M; Talento A; Fischer PA; Springer MS; Sigal NH; Slaughter RS; Garcia ML
J Exp Med; 1993 Mar; 177(3):637-45. PubMed ID: 7679705
[TBL] [Abstract][Full Text] [Related]
5. T cell activation is regulated by voltage-dependent and calcium-activated potassium channels.
Rader RK; Kahn LE; Anderson GD; Martin CL; Chinn KS; Gregory SA
J Immunol; 1996 Feb; 156(4):1425-30. PubMed ID: 8568243
[TBL] [Abstract][Full Text] [Related]
6. Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes.
Price M; Lee SC; Deutsch C
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10171-5. PubMed ID: 2481312
[TBL] [Abstract][Full Text] [Related]
7. Role of potassium channels in bronchodilator responses in human airways.
Miura M; Belvisi MG; Stretton CD; Yacoub MH; Barnes PJ
Am Rev Respir Dis; 1992 Jul; 146(1):132-6. PubMed ID: 1378252
[TBL] [Abstract][Full Text] [Related]
8. Investigation of K+ channel expression in human peripheral lymphocytes of healthy donors by means of flow cytometry.
Krjukova J; Osna N; Pilmane M
Scand J Clin Lab Invest; 2000 Aug; 60(5):419-27. PubMed ID: 11003262
[TBL] [Abstract][Full Text] [Related]
9. Blocking of human T lymphocyte activation by channel antagonists.
Bono MR; Simon V; Rosemblatt MS
Cell Biochem Funct; 1989 Jul; 7(3):219-26. PubMed ID: 2477169
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
Jones TR; Charette L; Garcia ML; Kaczorowski GJ
J Pharmacol Exp Ther; 1990 Nov; 255(2):697-706. PubMed ID: 1700817
[TBL] [Abstract][Full Text] [Related]
11. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin 2 production and alteration of interleukin 2 mRNA processing by human T-T cell hybridoma-derived suppressor factors.
Fox FE; Chernajovsky Y; Platsoucas CD
Hybridoma; 1994 Oct; 13(5):343-52. PubMed ID: 7860090
[TBL] [Abstract][Full Text] [Related]
14. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta.
Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA
J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
Stevens C; Lipman M; Fabry S; Moscovitch-Lopatin M; Almawi W; Keresztes S; Peppercorn MA; Strom TB
J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
[TBL] [Abstract][Full Text] [Related]
16. Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4.
Kawabe T; Maekawa N; Maeda Y; Hosoda M; Yodoi J
J Immunol; 1991 Jul; 147(2):548-53. PubMed ID: 1830067
[TBL] [Abstract][Full Text] [Related]
17. WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
Hill RJ; Grant AM; Volberg W; Rapp L; Faltynek C; Miller D; Pagani K; Baizman E; Wang S; Guiles JW
Mol Pharmacol; 1995 Jul; 48(1):98-104. PubMed ID: 7542739
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
Santoli D; Zurier RB
J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional modulation of human IL-6 gene expression by verapamil.
Walz G; Zanker B; Barth C; Wieder KJ; Clark SC; Strom TB
J Immunol; 1990 Jun; 144(11):4242-8. PubMed ID: 2341719
[TBL] [Abstract][Full Text] [Related]
20. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
